Skip to main content

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

COGT holding history

Cogent Biosciences, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

COGT overviewAll 13F holders of COGTFull Q2 2026 holdings

Shares (Q2 2026)
450,000
Value
$17.4M
% of portfolio
0.9%
Quarters held
7
Since Q2 2022
Holdings of COGT by Affinity Asset Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026450,000$17.4M0.9%−300,000−40.0%ReducedHolders
Q1 2026750,000$28.9M1.7%+400,000+114.3%AddedHolders
Q4 2025350,000$12.4M0.9%+350,000NewHolders
Q2 20230$00.0%−143,064−100.0%Sold outHolders
Q1 2023143,064$1.54M0.6%−50,000−25.9%ReducedHolders
Q4 2022193,064$2.23M1.0%+38,977+25.3%AddedHolders
Q3 2022154,087$2.30M1.1%+29,087+23.3%AddedHolders
Q2 2022125,000$1.13M0.6%+125,000NewHolders